Responses
E-Posters
E-Poster Viewing
EPV278/#248 A randomized controlled phase ii clinical trial of apatinib plus chemotherapy in the first-line(1L) treatment of ivb stage, recurrent or persistent cervical cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.